DITPA, a thyroid hormone analog, reduces infarct size and attenuates the inflammatory response following myocardial ischemia

Journal of Surgical Research

Volumn 171, Issue 2, 2011, Pages 379-385

  Abohashem Aly, Abdelrahman A ^a   Meng, Xianzhong ^a   Li, Jilin ^a   Sadaria, Miral R ^a   Ao, Lihua ^a   Wennergren, John ^a   Fullerton, David A ^a   Raeburn, Christopher D ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

animal model; inflammatory cells; myocardial ischemia; thyroid hormone analogs

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; THYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; IMMUNOFLUORESCENCE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; CHEMOKINE CCL2; CHEMOKINES; DIIODOTHYRONINES; DISEASE MODELS, ANIMAL; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; NEUTROPHILS; PROPIONIC ACIDS;

EID: 81155131773     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.04.009     Document Type: Article

References (47)

1. D. Lloyd-Jones, R. Adams, and T. Brown Heart disease and stroke statistics 2010 update: A report from the American Heart Association Circulation 121 2010 e46
2. C. Pantos, V. Malliopoulou, and D. Varonons Thyroid hormone and phenotypes of cardioprotection Basic Res Cardiol 99 2004 101
3. A.M. Ranasinghe, D.W. Quinn, and D. Pagano Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting Circulation 114 2006 I-245
4. I. Klein Thyroid hormone and cardiac contractility Am J Cardiol 91 2003 1327
5. I. Klein, and K. Ojamaa Thyroid hormone and the cardiovascular system N Engl J Med 344 2001 501
6. C.T. Sawin Subclinical hyperthyroidism and atrial fibrillation Thyroid 12 2002 501
7. C. Adamson, N. Maitra, and J. Bahl Regulation of gene expression in cardiomyocytes by thyroid hormone and thyroid hormone analogs 3,5-diiodothyropropionic acid and CGS 23425 [N-[3,5-dimethyl-4-(4′- hydroxy-3′-isopropylphenoxy)-phenyl]-oxamic acid] J Pharmacol Exp Ther 311 2004 164
8. G.D. Pennock, T.E. Raya, and J.J. Bahl Cardiac effects of DITPA, a thyroid hormone analog with inotropic selectivity J Pharmacol Exp Ther 263 1992 163
9. E. Morkin, P. Ladenson, and S. Goldman Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: Past, present, and future J Mol Cell Cardiol 37 2004 1137
10. W. Zheng, R.M. Weiss, and X. Wang DITPA stimulates arteriolar growth and modifies myocardial post-infarction remodeling Am J Physiol Heart Circ Physiol 286 2004 H1994
11. P.H. Spooner, E. Morkin, and S. Goldman Thyroid hormone and thyroid hormone analogues in the treatment of heart failure Coron Artery Dis 10 1999 395
12. K.W. Mahaffey, T.E. Raya, and G.D. Pennock Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue Circulation 91 1995 794
13. E. Morkin, G. Pennock, and P.H. Spooner Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure Cardiology 97 2002 218
14. S. Goldman, M. McCarren, and E. Morkin DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: Phase II trial veterans affairs cooperative study Circulation 119 2009 3093
15. N.G. Frangogiannis The immune system and cardiac repair Pharmacol Res 58 2008 88
16. G. Ertl, and S. Frantz Healing after myocardial infarction Cardiovasc Res 66 2005 22
17. S. Frantz, J. Bauersachs, and G. Ertl Post-infarct remodeling: Contribution of wound healing and inflammation Cardiovasc Res 81 2009 474
18. B. Jiang, and R. Liao The paradoxical role of inflammation in cardiac repair and regeneration J Cardiovasc Transl Res 3 2010 410
19. B. Eber, M. Schumacher, and W. Langsteger Changes in thyroid hormone parameters after acute myocardial infarction Cardiology 86 1995 152
20. L. Friberg, S. Werner, and G. Eggertsen Rapid down-regulation of thyroid hormones in acute myocardial infarction: Is it cardioprotective in patients with angina? Arch Intern Med 162 2002 1388
21. V. Lubrano, A. Pingitore, and A. Carpi Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure Biomed Pharmacother 64 2010 165
22. M. Nishino, T. Kimura, and T. Kanda Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure J Endocrinol Invest 23 2000 509
23. G. Iervasi, A. Pingitore, and P. Landi Low-T3 syndrome: A strong prognostic predictor of death in patients with heart disease Circulation 107 2003 708
24. G.D. Pennock, T.E. Raya, and J.J. Bahl Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid. A new approach to improving left ventricular performance in heart failure Circulation 88 1993 1289
25. N. Zou, L. Ao, and J.C. Cleveland Jr. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion Am J Physiol Heart Circ Physiol 294 2008 H2805
26. L. Ao, Y. Song, and D.A. Fullerton The interaction between myocardial depressant factors in endotoxemic cardiac dysfunction: Role of TNF-α in TLR4-mediated ICAM-1 expression Cytokine 38 2007 124
27. N.G. Frangogiannis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31
28. M.R. Litt, R.W. Jeremy, and H.F. Weisman Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury Circulation 80 1989 1816
29. H. Kin, N.P. Wang, and M.E. Halkos Neutrophil depletion reduces myocardial apoptosis and attenuates NFκB activation/TNFα release after ischemia and reperfusion J Surg Res 135 2006 170
30. G.M. Palatianos, G. Balentine, and E.G. Papadakis Neutrophil depletion reduces myocardial reperfusion morbidity Ann Thorac Surg 77 2004 956
31. G. Ren, O. Dewald, and N.G. Frangogiannis Inflammatory mechanisms in myocardial infarction Curr Drug Targets Inflamm Allergy 2 2003 242
32. L. Lu, S.S. Chen, and J.Q. Zhang Activation of nuclear factor-κB and its proinflammatory mediator cascade in the infarcted rat heart Biochem Biophys Res Commun 321 2004 879
33. Z.H. Ren, Y.H. Tong, and W. Xu Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression Phytomedicine 17 2010 212
34. D. Fraccarollo, P. Galuppo, and S. Schraut Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response Hypertension 51 2008 905
35. W. Zhao, L. Lu, S.S. Chen, and Y. Sun Temporal and spatial characteristics of apoptosis in the infarcted rat heart Biochem Biophys Res Commun 325 2004 605
36. G.E. González, I.M. Seropian, and M.L. Krieger Effect of early versus late AT(1) receptor blockade with losartan on post-myocardial infarction ventricular remodeling in rabbits Am J Physiol Heart Circ Physiol 297 2009 H375
37. P. Panizzi, F.K. Swirski, and J.L. Figueiredo Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis J Am Coll Cardiol 55 2010 1629
38. M. Nahrendorf, F.K. Swirski, and E. Aikawa The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions J Exp Med 204 2007 3037
39. Y.N. Nabah, T. Mateo, and R. Estellés Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines Circulation 110 2004 3581
40. N. Sekido, N. Mukaida, and A. Harada Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 Nature 365 1993 654
41. W.A. Boisvert, D.M. Rose, and K.A. Johnson Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression Am J Pathol 168 2006 1385
42. Y. Huo, C. Weber, and S.B. Forlow The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium J Clin Invest 108 2001 1307
43. T. Sato, H. Suzuki, and M. Shibata Tumor-necrosis-factor-α-gene- deficient mice have improved cardiac function through reduction of intercellular adhesion molecule-1 in myocardial infarction Circ J 70 2006 1635
44. C. Raeburn, C. Calkins, and M. Zimmerman ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation Am J Physiol Regul Integr Comp Physiol 283 2002 R477
45. A.J. Palazzo, S.P. Jones, and W.G. Girod Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice Am J Physiol 275 1998 H2300
46. M. Kobara, K. Noda, and M. Kitamura Antibody against interleukin-6 receptor attenuates left ventricular remodeling after myocardial infarction in mice Cardiovasc Res 87 2010 424
47. A. Pingitore, G. Iervasi, and M.A. Gerdes Letter by Pingitore et al. regarding article, "DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: Phase II trial Veterans Affairs cooperative study." Circulation 121 2010 e240